These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1328516)

  • 1. Altered microviscosity at brain membrane surface induces distinct and reversible inhibition of opioid receptor binding.
    Lazar DF; Medzihradsky F
    J Neurochem; 1992 Oct; 59(4):1233-40. PubMed ID: 1328516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of opioid receptor binding by cis and trans fatty acids.
    Remmers AE; Nordby GL; Medzihradsky F
    J Neurochem; 1990 Dec; 55(6):1993-2000. PubMed ID: 2172466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig.
    Clark MJ; Carter BD; Medzihradsky F
    Eur J Pharmacol; 1988 Apr; 148(3):343-51. PubMed ID: 2898375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered transition between agonist- and antagonist-favoring states of mu-opioid receptor in brain membranes with modified microviscosity.
    Lazar DF; Medzihradsky F
    J Neurochem; 1993 Sep; 61(3):1135-40. PubMed ID: 8395559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy.
    Emmerson PJ; Clark MJ; Medzihradsky F; Remmers AE
    J Neurochem; 1999 Jul; 73(1):289-300. PubMed ID: 10386982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
    Obermeier H; Wehmeyer A; Schulz R
    Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dog cerebral cortex contains mu-, delta- and kappa-opioid receptors at different densities: apparent lack of evidence for subtypes of the kappa-receptor using selective radioligands.
    Sharif NA; Durie E; Michel AD; Whiting RL
    Brain Res; 1990 Feb; 510(1):108-14. PubMed ID: 2157522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of opioid receptors in intestinal muscle cells by selective radioligands and receptor protection.
    Kuemmerle JF; Makhlouf GM
    Am J Physiol; 1992 Aug; 263(2 Pt 1):G269-76. PubMed ID: 1325129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
    Newman LC; Sands SS; Wallace DR; Stevens CW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of biphasic binding of the opioid antagonist naltrexone in brain membranes.
    Remmers AE; Medzihradsky F
    J Neurochem; 1991 Oct; 57(4):1265-9. PubMed ID: 1654389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.